Lumbrokinase is used for the treatment and prevention of thrombotic and thromboembolic diseases; it is effective in managing ischemic cerebrovascular disorders, particularly in patients with elevated fibrinogen levels and platelet aggregation; it aids in the recovery of limb paralysis and speech disturbances caused by stroke; it is also applied in the treatment of transient ischemic attacks, early-stage cerebral thrombosis, coronary heart disease, myocardial infarction, sudden deafness, retinitis, central retinal vein occlusion, pulmonary embolism, and peripheral vascular embolism.